New and Generic Drug Approvals
September 19, 2014
| Drug Name | Active Ingredient | Dosage Form/Route | Sponsor | Submission Type |
|---|---|---|---|---|
| Ammonia N 13 Injection | ammonia n 13 injection | Injectable;Injection | Shertech Labs Llc | Approval |
| Chantix | varenicline tartrate | Tablet;Oral | Pfizer Inc | Efficacy Supplement with Clinical Data to Support |
| Chantix | varenicline tartrate | Tablet;Oral | Pfizer Inc | Labeling Revision |
| Janumet Xr | metformin hydrochloride; sitagliptin phosphate | Tablet, Extended Release;Oral | Merck Sharp Dohme | Manufacturing Change or Addition |
| Lexiscan | regadenoson | Solution;Intravenous | Astellas | Labeling Revision |
| Lumigan | bimatoprost | Solution/Drops;Ophthalmic | Allergan | Manufacturing Change or Addition |
| Marcaine | bupivacaine hydrochloride | Injectable;Spinal | Hospira | Manufacturing Change or Addition |
| Marcaine Hydrochloride | bupivacaine hydrochloride | Injectable;Injection | Hospira | Manufacturing Change or Addition |
| Marcaine Hydrochloride Preservative Free | bupivacaine hydrochloride | Injectable;Injection | Hospira | Manufacturing Change or Addition |
| Marcaine Hydrochloride W/ Epinephrine | bupivacaine hydrochloride; epinephrine bitartrate | Injectable;Injection | Hospira | Manufacturing Change or Addition |
| Marcaine Hydrochloride W/ Epinephrine Preservative Free | bupivacaine hydrochloride; epinephrine bitartrate | Injectable;Injection | Hospira | Manufacturing Change or Addition |
| Nasacort Allergy 24 Hour | triamcinolone acetonide | Spray, Metered;Nasal | Sanofi Aventis Us | Labeling Revision |
| Otezla | apremilast | Tablet;Oral | Celgene Corp | Manufacturing Change or Addition |
| Pentostatin | pentostatin | Injectable;Injection | Mylan Institutional | Approval |
| Rizatriptan Benzoate | rizatriptan benzoate | Tablet, Orally Disintegrating;Oral | Macleods Pharms Ltd | Approval |
| Temodar | temozolomide | Capsule;Oral | Merck Sharp Dohme | Manufacturing Change or Addition |
No comments:
Post a Comment